(NASDAQ: FLGT) Fulgent Genetics's forecast annual revenue growth rate of 8.32% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.13%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.36%.
Fulgent Genetics's revenue in 2025 is $292,448,000.On average, 2 Wall Street analysts forecast FLGT's revenue for 2025 to be $9,433,556,783, with the lowest FLGT revenue forecast at $9,400,982,136, and the highest FLGT revenue forecast at $9,466,131,429. On average, 2 Wall Street analysts forecast FLGT's revenue for 2026 to be $10,440,783,123, with the lowest FLGT revenue forecast at $10,353,866,660, and the highest FLGT revenue forecast at $10,527,699,587.
In 2027, FLGT is forecast to generate $11,465,818,967 in revenue, with the lowest revenue forecast at $11,404,170,687 and the highest revenue forecast at $11,527,467,247.